EW

EW Stock-Based Compensation

$168.00MTTM · USD

Period ending:

EW FY Stock-Based CompUSD
EW FY Stock-Based Comp1999-12-31: $0.002000-12-31: $0.002001-12-31: $0.002002-12-31: $0.002003-12-31: $0.002004-12-31: $0.002005-12-31: $0.002006-12-31: $26.60M2007-12-31: $27.70M2008-12-31: $28.70M2009-12-31: $28.30M2010-12-31: $29.30M2011-12-31: $35.00M2012-12-31: $42.10M2013-12-31: $47.40M2014-12-31: $48.30M2015-12-31: $49.90M2016-12-31: $56.90M2017-12-31: $61.60M2018-12-31: $71.00M2019-12-31: $81.30M2020-12-31: $92.60M2021-12-31: $109.30M2022-12-31: $126.80M2023-12-31: $139.40M2024-12-31: $162.30M2025-12-31: $158.10M$162.30M$0.00
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

EW stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Edwards Lifesciences Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
158,100,000
162,300,000
139,400,000
126,800,000
109,300,000
92,600,000
81,300,000
71,000,000
61,600,000
56,900,000
49,900,000
48,300,000
47,400,000
42,100,000
35,000,000
29,300,000
28,300,000
28,700,000
27,700,000
26,600,000
0
0
0
0
0
0
0

Compare stock-based compensation

All EW financial metrics · EW stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.